Evidence map

ReviewDiabetology & metabolic syndrome2021

Advances in GLP-1 treatment: focus on oral semaglutide.

Freddy G Eliaschewitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34526121